PubMed Health⌕ Search

Biomedical subjects

Edward J Stepanski

Publications and source records attributed to Edward J Stepanski.

11 recordsLinked to original sources
PubMed2006

Circadian phase in delayed sleep phase syndrome: predictors and temporal stability across multiple assessments.

STUDY OBJECTIVES: To assess temporal stability across multiple assessments and predictors of circadian phase in participants with delayed sleep phase syndrome (DSPS), relative to normal-sleeping matched controls. DESIGN: Circadian phase was assessed by salivary dim light melatonin onset (DLMO) during 3 laboratory visits, separated by at least 5 days--2 scheduled at the end of the week (Friday) and 1 scheduled at the end of the weekend (Sunday). PATIENTS: Eight young volunteers who met International Classification of Sleep Disorders-Revised criteria for DSPS, and 8 age- and sex-matched controls (age range 19-27 years old). INTERVENTIONS: N/A. MEASUREMENTS AND RESULTS: As expected, salivary DLMO occurred significantly later in patients with DSPS than in controls (F 10.561, p = .006). However, circadian phase did not change significantly across the 3 DLMO assessments in either group. Estimations of circadian phase were not significantly different in the assessments conducted on weekdays versus weekends. Predictors of circadian phase included time of morning light exposure (R2 = 0.777; p < .001), recent wake time (R2 = 0.701, p < .001), and self-reported chronotype (R2 = 0.320, p = .016). DLMO preceded wake time in both groups by approximately 10.75 hours. CONCLUSIONS: Across serial laboratory assessments on an ad lib sleep schedule, patients with DSPS appeared more similar to than different from normal-sleeping control subjects, except for a stable delay in circadian phase.

Adult↗
PubMed2006

Recent developments in the classification, evaluation, and treatment of insomnia.

Sleep/wake complaints, and specifically insomnia, are some of the more common problems encountered in the outpatient setting. Despite its prevalence, few clinicians are experts at diagnosing and treating this entity. Additionally, diagnosis and treatment of insomnia is a time-intensive process (often the initial interview takes at least 1 h, depending on the complexity of the insomnia). With a conservative estimate of the annual cost of insomnia between dollar 92.5 and dollar 107.5 billion dollars, it is becoming clear that insomnia has significant medical and public health implications. A problem that has hampered insomnia research is the lack of a standard definition of insomnia for use in research, as well as guidelines for assessment. In recent years, there have been important advances in the classification, evaluation, and treatment of insomnia with efforts to establish greater consensus in how to define and measure insomnia. Cognitive behavioral and pharmacologic therapies have been shown to be effective treatment approaches. Insomnia is a complex entity, often multifactorial in its etiology; and as research and clinical guidelines are established and validated (leading to better data interpretation), continued enhancement of our understanding of this disorder is expected.

Cognitive Behavioral Therapy↗
PubMed2005

Emerging research on the treatment and etiology of secondary or comorbid insomnia.

Secondary insomnia is defined as difficulty initiating or maintaining sleep that occurs as a consequence of another primary medical or psychiatric disorder. This distinction from primary insomnia has been thought to be important from a diagnostic standpoint so that treatment for secondary insomnia can appropriately target the primary disorder. By convention, treating insomnia directly has only been recommended with primary insomnia. However, a number of recent studies of cognitive-behavioral treatment for a wide range of secondary insomnias have demonstrated that this approach is an effective treatment in this population. These results are not predicted by the traditional conceptualization of secondary insomnia. Results of epidemiological research also argue against viewing insomnia that is comorbid with another disorder as being caused by that disorder. A revised model is needed to understand insomnia that is comorbid with medical and/or psychiatric illness, in addition to re-evaluating standard treatment protocols for comorbid insomnia.

Arousal↗
PubMed2004

Derivation of research diagnostic criteria for insomnia: report of an American Academy of Sleep Medicine Work Group.

Insomnia is a highly prevalent, often debilitating, and economically burdensome form of sleep disturbance caused by various situational, medical, emotional, environmental and behavioral factors. Although several consensually-derived nosologies have described numerous insomnia phenotypes, research concerning these phenotypes has been greatly hampered by a lack of widely accepted operational research diagnostic criteria (RDC) for their definition. The lack of RDC has, in turn, led to inconsistent research findings for most phenotypes largely due to the variable definitions used for their ascertainment. Given this problem, the American Academy of Sleep Medicine (AASM) commissioned a Work Group (WG) to review the literature and identify those insomnia phenotypes that appear most valid and tenable. In addition, this WG was asked to derive standardized RDC for these phenotypes and recommend assessment procedures for their ascertainment. This report outlines the WG's findings, the insomnia RDC derived, and research assessment procedures the WG recommends for identifying study participants who meet these RDC.

Diagnostic and Statistical Manual of Mental Disord↗
PubMed2004

Daytime sleepiness and alertness in patients with Parkinson disease.

STUDY OBJECTIVES: The goal of the study was to objectively measure daytime sleepiness and alertness in patients undergoing treatment for idiopathic Parkinson disease (PD) and assess potential contributing factors. DESIGN: Prospective study. SETTING: An accredited sleep disorders center in a university-based medical center in a large urban area. PATIENTS: Twenty consecutive subjects with idiopathic PD were recruited from a tertiary-care movement disorders clinic. INTERVENTIONS: N/A. MEASUREMENTS AND RESULTS: Patients underwent polysomnography, with a Multiple Sleep Latency Test (MSLT) and a Maintenance of Wakefulness Test (MWT) on the following day. Forty-seven percent of the sample was pathologically sleepy according to the MSLT, but only 26% had abnormal MWT scores. There was also a different pattern of correlations between predictors of sleepiness and MSLT and MWT scores. Percentage of stage 1 sleep had the largest correlation with MSLT (-0.42), while pergolide equivalents had the largest correlation with MWT (-0.70). CONCLUSIONS: In this sample of subjects with PD, severe daytime sleepiness was common and was related to poor sleep quality. Daytime alertness as measured by the MWT was impaired as medication burden increased.

Adult↗
PubMed2003

Use of sleep hygiene in the treatment of insomnia.

Sleep hygiene (SH) refers to a list of behaviors, environmental conditions, and other sleep-related factors that can be adjusted as a stand-alone treatment or component of multimodal treatment for patients with insomnia. This paper presents a review of SH, how this concept has been applied and often modified over the past 24 years, and how it relates to the modern sleep disorder nosology, particularly Inadequate Sleep Hygiene. Although a recognized and commonly utilized treatment option, there is no absolute consensus about which steps must be included to constitute SH treatment, and there is much overlap between SH and other cognitive-behavioral treatments for insomnia such as Stimulus Control Procedures and Sleep Restriction Therapy. The literature on the effects of manipulations of individual components of SH under experimental conditions (e.g. effects of presleep alcohol or caffeine intake) in normal sleepers show mixed results. Empirical data demonstrating the role of poor SH as a contributor to insomnia, or showing that good SH improves sleep in patients with insomnia, is not available. Instead of evaluating the impact of a comprehensive list of SH recommendations, a focus on guidelines for use of individual rules is needed.

Body Temperature↗
PubMed2003

Behavioral sleep medicine: a historical perspective.

Behavioral sleep medicine (BSM) has recently emerged as a subspecialty area within the broader field of sleep medicine. Certain commonly used treatment approaches in BSM were first pioneered in the 1930s, and this article traces the developments within BSM to current practice. Important innovations include the expansion of BSM beyond the treatment of insomnia to include treatment of pediatric sleep disorders, circadian rhythm disorders, parasomnias, as well as desensitization procedures for patients undergoing treatment with nasal continuous positive airway pressure (CPAP).

Behavioral Medicine↗
PubMed2002

The effect of sleep fragmentation on daytime function.

It is clear from this literature that fragmented sleep is less restorative than consolidated sleep, and leads to sleepiness-related daytime impairment. The optimal approach to the quantification of sleep fragmentation continues to be debated. Modest and erratic correlations between measures of sleepiness and traditional measures of EEG arousals have pushed investigators to try and find more sensitive measures of sleep fragmentation. Simply correlating various measures of sleep fragmentation with a measure of sleepiness has significant limitations. Since sleep fragmentation is not the only factor affecting daytime sleepiness, these correlations can be misleading. For example, a subject with severely fragmented sleep will show elevated sleepiness during the day. However, the overall correlation may be reduced because lack of fragmented sleep does not guarantee that the level of sleepiness will be low. Multivariate statistical modeling is needed to account for sources of variance simultaneously in the prediction of daytime sleepiness. In this way it may be possible to identify the optimal definition of sleep fragmentation. More studies are needed that evaluate "sub-cortical" arousals, EEG arousals, and daytime function simultaneously. Ideally, clarification of these measurement issues will lead to an improved understanding of sleep structure and the mechanism through which sleep fragmentation impacts daytime function.

Adult↗
PubMed2002

Sleep and quality of life in breast cancer patients.

This study described sleep in a heterogeneous sample of breast cancer patients using the Pittsburgh Sleep Quality Index (PSQI) and examined the relation between sleep disturbance and health-related quality of life as measured by the Rand 36-Item Health Survey. Chemotherapy and radiation therapy were explored as predictors of sleep disturbance in breast cancer patients, and the sleep characteristics of breast cancer patients were compared to the sleep characteristics of a sample of medical patients with general medical conditions. Results showed that 61% of breast cancer patients had significant sleep problems. Sleep was characterized by reduced total sleep time with sleep frequently being disturbed by pain, nocturia, feeling too hot, and coughing or snoring loudly. Despite the frequency of significant sleep disturbance, pharmacological and cognitive-behavioral treatments of sleep problems were observed to be inadequate. Limited evidence was found for the role of chemotherapy and radiation therapy in the sleep disturbance of breast cancer patients, and the general pattern of sleep disturbance in breast cancer patients was not significantly different than that observed in medical patients with general medical conditions. Breast cancer patients having significant sleep problems had greater deficits in many areas of health-related quality of life. The implications of the findings and study limitations are discussed.

Adult↗